These 4 Measures Indicate That Aurobindo Pharma (NSE:AUROPHARMA) Is Using Debt Reasonably Well
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Has the Indian Healthcare Sector valuation changed over the past few years?
|Sun, 28 Nov 2021||₹14.9t||₹3.4t||₹435.3b||25x|
|Tue, 26 Oct 2021||₹14.6t||₹3.3t||₹442.8b||25.3x|
|Thu, 23 Sep 2021||₹15.5t||₹3.3t||₹440.6b||27.1x|
|Sat, 21 Aug 2021||₹14.9t||₹3.3t||₹439.1b||25.7x|
|Sat, 05 Jun 2021||₹14.0t||₹3.1t||₹364.6b||24.1x|
|Tue, 09 Mar 2021||₹11.9t||₹3.0t||₹349.5b||21.6x|
|Mon, 30 Nov 2020||₹11.7t||₹3.0t||₹269.2b||24.7x|
|Thu, 03 Sep 2020||₹10.3t||₹2.9t||₹236.8b||23.8x|
|Sun, 07 Jun 2020||₹8.7t||₹2.9t||₹262.6b||18.4x|
|Sat, 29 Feb 2020||₹7.6t||₹2.9t||₹245.9b||16.8x|
|Tue, 03 Dec 2019||₹7.5t||₹2.8t||₹269.4b||18x|
|Fri, 06 Sep 2019||₹6.9t||₹2.7t||₹257.0b||17.6x|
|Mon, 10 Jun 2019||₹7.1t||₹2.6t||₹241.1b||20.4x|
|Sun, 03 Mar 2019||₹7.3t||₹2.5t||₹213.1b||21.7x|
|Wed, 05 Dec 2018||₹7.7t||₹2.4t||₹202.6b||22.6x|
Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 21.0x. It appears they believe that earnings will grow in-line with historical growth rates.
Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 29% per year over the last three years, and revenues for these companies have grown 11% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Which industries have driven the changes within the Indian Healthcare sector?
Industry PE: Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 45.0x. This is likely because analysts are expecting annual earnings growth of 43%, which is higher than its past year's earnings growth of 31% per year. Meanwhile, investors are most pessimistic about the Pharma industry. Although, investor sentiment seems to have improved given its trading above its 3-year average of 19.3x.
Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 43% over the next 5 years. This is better than it's past earnings growth rate of 31% per year. Meanwhile, the Healthcare Services industry is expected to see its earnings grow by 17% per year over the next few years.
Which companies have driven the market over the last 7 days?
Apollo Hospitals Enterprise
Sun Pharmaceutical Industries
Max Healthcare Institute
Caplin Point Laboratories